ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 101,513 shares, the number of shares held increased 0.83% compared to the previous period and now represents 2.15% of the total position.

ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 5,190 shares, the number of shares held increased 0.29% compared to the previous period and now represents 4.41% of the total position.

ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 24,295 shares, the number of shares held increased 0.83% compared to the previous period and now represents 3.33% of the total position.

ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 18,932 shares, the number of shares held decreased 1.56% compared to the previous period and now represents 3.85% of the total position.

ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 1,064 shares, the number of shares held increased 4.25% compared to the previous period and now represents 1.05% of the total position.

ARKG Investment Tracker position change: Increased position in Veracyte by 56,810 shares, the number of shares held increased 4.23% compared to the previous period and now represents 5.24% of the total position.

ARKG Investment Tracker position change: Increased position in Veeva by 836 shares, the number of shares held increased 1.09% compared to the previous period and now represents 1.53% of the total position.

ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 111,758 shares, the number of shares held increased 4.23% compared to the previous period and now represents 3.39% of the total position.

ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 91,238 shares, the number of shares held increased 4.23% compared to the previous period and now represents 9.26% of the total position.

ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 92,454 shares, the number of shares held increased 4.23% compared to the previous period and now represents 4.11% of the total position.

ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 488,110 shares, the number of shares held increased 4.23% compared to the previous period and now represents 7.25% of the total position.

ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 532 shares, the number of shares held increased 4.07% compared to the previous period and now represents 0.86% of the total position.

ARKG Investment Tracker position change: Increased position in Natera by 13,946 shares, the number of shares held increased 4.23% compared to the previous period and now represents 4.96% of the total position.

ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 496,698 shares, the number of shares held increased 4.23% compared to the previous period and now represents 2.08% of the total position.

ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 124,943 shares, the number of shares held increased 4.48% compared to the previous period and now represents 3.26% of the total position.

ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 23,940 shares, the number of shares held increased 2.02% compared to the previous period and now represents 3.84% of the total position.

ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 60,268 shares, the number of shares held increased 4.23% compared to the previous period and now represents 4.47% of the total position.

ARKG Investment Tracker position change: Increased position in Illumina by 4,180 shares, the number of shares held increased 4.25% compared to the previous period and now represents 1.28% of the total position.

ARKG Investment Tracker position change: Increased position in Incyte by 6,764 shares, the number of shares held increased 4.23% compared to the previous period and now represents 0.99% of the total position.

ARKG Investment Tracker position change: Increased position in Exact Sciences by 3,344 shares, the number of shares held increased 4.27% compared to the previous period and now represents 0.43% of the total position.